ABSTRACT
binding protein 4 (GATA4) (7) and T-box transcription factor 5 (Tbx5) (2), manifest cardiac 89 septation defects. These three transcription factors interact with each other to form complexes in 90 driving cardiac gene expression during cardiogenesis, and they also promote cell proliferation by 91 inducing cyclin D2 and CKD4 transcription (33). We hypothesize that maternal diabetes impedes 92 the BMP4 pathway and suppresses the expression of cardiogenesis factors.
93
In the present study, we investigated the role of ASK1 in maternal diabetes-induced heart 94 defects. We found that the ASK1-JNK1/2 pathway was activated in the developing heart by 95 maternal diabetes. Moreover, inactivation of this pathway by deleting Ask1, ameliorated the 96 incidence of heart defects by suppressing the ER stress-induced apoptotic response. Ask1 97 deletion also restored cell cycle progression by reversing the alteration in cardiac specific 98 transcription factors, cyclin D and cell cycle inhibitors. Our studies support a critical role for 99 ASK1 in maternal diabetes-induced VSDs and OFT defects. 
METHODS

102
Mice and reagents
103
Wild-type (WT) C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME).
104
Ask1-/-mice in C57BL/6J background were provided by Dr. Hidenori Ichijo at the University of 
Mouse models of diabetic embryopathy
109
Mouse models of maternal diabetes-induced embryonic malformations were described 110 previously (18, 57) . Briefly, ten-week old WT and Ask1 -/-female mice were intravenously 111 injected daily with 75 mg/kg STZ over two days to induce diabetes. Using STZ to induce 112 diabetes is not a complicating factor because STZ is cleared from the bloodstream rapidly (serum 113 half-life, 15 minutes) (36), and pregnancy is not established until one-to-two weeks after STZ 114 injection (59). Diabetes was defined as a 12-hour fasting blood glucose level of ≥ 14 mM. Male 115 and female mice were paired at 3:00 P.M., and day 0.5 (E0.5) of pregnancy was established at 116 noon of the day when a vaginal plug was present. Nondiabetic controls were established by 117 injecting WT female mice with vehicle. Embryonic hearts were harvested for analyses on E12.5 118 and 17.5.
119
India ink injection and Hematoxylin-eosin staining
120
After euthanizing the pregnant dams on E17.5, fetuses were excised from uteri and 121 decapitated. Then, the rib cage was removed, and the hearts were exposed while remained 122 attaching to the spine. India Ink was injected using μTIP (TIP10TW1-L, world precision 123 instrument, Inc., Sarasota, FL) directed into the left ventricle using the apex of the heart as an 124 anatomical landmark. . Hearts were then fixed in methacarn (methanol, 60%; chloroform, 30%; 125 glacial acetic acid, 10%), embedded in paraffin, and cut into 8-μm sections. After 126 deparaffinization and rehydration, all specimens then underwent hematoxylin and eosin (H&E) 127 staining in a standard procedure. All heart sections were photographed and examined for heart 128 defects.
129
Western blotting
130
Western blotting was performed as previously described (17, 57) . Briefly, E12.5 131 embryonic hearts were sonicated in ice-cold RIPA lysis buffer (Millipore, Bedford, MA).
132
Proteins were separated by SDS-PAGE and immunoblotted using primary antibodies for BiP
133
(immunoglobulin heavy-chain binding protein), CHOP (C/EBP homologous protein), phosphor-
134
(p-)-PERK (PKR-like ER kinase), p-eIF2α (eucaryotic translation initiation factor 2alpha), p-
135
IRE1α, p-c-jun, p-JNK1/2, p-Elk1 (ETS domain-containing protein 1), p-ATF2 (Activating 136 transcription factor 2), p-smad1/5/8, CDK2, CDK4, CyclinD1, CyclinD2, cyclin D3, p21, p27, 137 ASK1, p-ASK1, caspase 3, caspase 8 and p-Histone H3. The intensity of the protein bands was 138 determined by densitometry and normalized by the densities of β-actin. Signals were detected 139 using SuperSignal West Femto kit (Thermo Scientific, Rockford, IL). 
Real-time PCR
149
Total RNA was isolated from hearts using an RNeasy Mini Kit (Qiagen, Valencia, CA) 150 and reverse transcribed using the high-capacity cDNA archive kit (Applied Biosystem, Grand
151
Island, NY). Gata4, Tbx5, P21, P27, CDK2, CDK4, CyclinD1, CyclinD2, 152 CyclinD3 and β-actin were performed using Maxima SYBR Green/ROX qPCR Master Mix 153 assay (Thermo Scientific, Rockford, IL). RT-PCR was performed using the StepOnePlus system 154 (Applied Biosystem, Grand Island, NY).
155
Immunofluorescence
156
E12.5 hearts were fixed in 4% paraformaldehyde overnight followed by embedding in 157 OCT (Sakura finetek, Torrance, CA) compound. 10-μm heart cryosections were antigen-158 unmasked using citrate buffer and blocked in 5% bovine serum albumin in PBST (0.1% Triton 159 X-100 in PBS) for 1 hour. The following antibodies were used as primary antibodies: p-ASK1
160
(1:200), p-Histone H3 (1:100) (Millipore, Bedford, MA). Normal rabbit or mouse IgG at the 161 same dilutions as those for antibodies were used as controls. Sections were counterstained with 162 DAPI and mounted with aqueous mounting medium (Sigma, St Louis, MO). Images were 163 captured using an inverted microscope (Nikon Eclipse E1000M). For the evaluation of cell 164 proliferation, p-Histone H3 positive cells were counted on three heart sections from embryos of 165 three different dams per group.
166
TUNEL Assay
167
The TUNEL assay was performed using the In Situ Cell Death Detection Kit (Millipore, 168 Billerica, MA)(57). 10-μm serial heart frozen sections were fixed with 4% paraformaldehyde and 
Statistical analyses
174
Data on heart defect rates were analyzed by Chi square test. Data on protein and mRNA 175 expression are presented as means ± standard errors. . Two way ANOVA and One way ANOVA 176 were performed using the SigmaStat 3.5 software followed by Holm-Sidak and Tukey test to 177 estimate significance. Statistical significance was accepted when P < 0.05.
178
RESULTS
179
Maternal diabetes activates ASK1 in the developing heart 180 To assess whether ASK1 is activated by maternal diabetes in the developing heart, we diabetes significantly increased the levels of p-ASK1 in E12.5 hearts (Fig. 1A) Fig. 2A ). VSD hearts were identified in 208 12.7 % of embryos exposed to maternal diabetes, using serial cross sections and HE staining 209 (Table 1 and Fig. 2A ). The VSDs in anterior positions ( Fig. 2A) were located in the cardiac 210 outlet and associated with an over-riding aorta ( Fig. 2A) . Posterior VSDs were large and located 211 in the muscular septum ( Fig. 2A) .
212
To test whether Ask1 gene deletion ameliorates maternal diabetes-induced heart defects,
213
we examined the incidences of heart defects in wild-type (WT) and Ask1 (Fig. 2B) , and Ask1 gene deletion blocked the cleavage 225 of these two caspases induced by maternal diabetes (Fig. 2B) . TUNEL assay detected excess 226 apoptotic cells in the AV cushion, the ventricular myocardium and the OFT in embryonic hearts 227 from diabetic dams (Fig. 2C, D) . The number of apoptotic cells was significantly higher in WT 228 embryonic hearts from diabetic dams than those in WT embryonic hearts from nondiabetic dams were significantly higher in embryonic hearts of diabetic dams than in embryonic hearts of 239 nondiabetic dams. Ask1 deletion suppressed maternal diabetes-increased phosphorylation of 240 these three transcription factors (Fig. 3B) . Levels of p-FoxO3a, an inactive form, were higher in 241 embryonic hearts of nondiabetic dams than in embryonic hearts of diabetic dams. Ask1 deletion 242 abrogated diabetes-reduced FoxO3a phosphorylation (activation) (Fig. 3B ).
243
Both JNK1/2 activation and ER stress lead to apoptosis in diabetic embryopathy (18). In 244 addition, JNK1/2 activation causes ER stress (18). To investigate whether maternal diabetes 245 induces ER stress in the developing heart, we measured the levels of ER markers. Levels of ER 246 stress markers, p-PERK, p-eIF2α, p-IRE1α, BiP and CHOP were significantly increased in 247 hearts of embryos from diabetic dams than in hearts of embryos from nondiabetic dams (Fig. 4A ).
248
Ask1 gene deletion abrogated the increase of ER stress marker expression (Fig. 4A ). In addition, 249 robust XBP1 (X-box binding protein 1) splicing, another indicator of ER stress, was observed in 250 embryonic hearts exposed to maternal diabetes, whereas there was no XBP1 splicing in WT BMP4 is critical for embryonic cardiogenesis and its deletion causes heart defects (24) 267 that are similar to the defects observed in diabetic pregnancies. To determine whether maternal 268 diabetes influences BMP4 expression, mRNA and protein levels of BMP4 were measured.
269
Maternal diabetes suppressed BMP4 mRNA and protein expression ( Mutations of transcription factors, Nkx2.5, GATA4 and Tbx5, results in VSD formation 277 (2, 7, 37). To reveal whether maternal diabetes affects the expression of these transcription 278 factors, mRNA levels of Nkx2.5, GATA4 and Tbx5 were assessed. Maternal diabetes suppressed 279 the expression of Nkx2.5 and GATA4, but did not affect the expression of Tbx5 (Fig. 7) . Ask1 280 gene deletion restored the expression of Nkx2.5 and GATA4 (Fig. 7) . causative relationship between the JNK1/2 pathway and ER stress (18). Indeed, along with 300 JNK1/2 activation, ER stress is manifested in the developing heart exposed to diabetes. ER stress 301 is the consequence of ASK1 activation, suggesting that the two interrelated proapoptotic 302 pathways, the JNK1/2 pathway and the ER stress pathway, act cooperatively in mediating the 303 teratogenic effect of ASK1. (14), supporting the causal role of impaired cell proliferation 320 in defective heart formation.. We found that diabetes differentially regulates the three cyclin Ds.
321
This differential regulation has been reported in the liver (31). Down-regulation of cyclin D1 by 322 diabetes is in agreement with a recent study in the chick model (38). Cyclin D2 is a GATA4 323 cofactor in cardiogenesis (54); however, we did not observe any changes of cyclin D2 expression.
324
In the neonatal heart, GATA4 induces cyclin D2 transcription (55). In our study, reduced 325 GATA4 expression does not cause cyclin D2 down-regulation. This discrepancy may be due to 326 difference in developmental timing or other tissue specific differences. Thus, our study reveals 327 that maternal diabetes impedes embryonic heart cell cycle progression by suppressing cyclin D1 328 and D3 expression and concomitantly increasing expression of cell cycle inhibitor, p21 and p27 329 (Fig. 7B) . (Fig. 7B) . diabetes-induced heart defects. However, we found that embryonic hearts had the highest ASK1 359 levels compared with other embryonic tissues, questioning whether ASK1 overexpression would 360 result in additive effects. Our study reveals that ASK1 activation is responsible for diabetes-361 induced heart defects. One reverse experiment may use a constitutively active ASK1 transgenic 362 line to determine whether ASK1 activation mimics maternal diabetes to induce heart defects.
363
Additionally, the inducible ASK1 transgenic mice (19) may not be suitable for our study because Hyperglycemia but not the types of diabetes determines the incidence of birth defects.
369
Clinical studies have revealed a strong correlation between the degree of maternal hyperglycemia 370 and the rate and severity of birth defects (8, 22, 41 marker for diabetes-induced heart defects.
387
In summary, ASK1 activation has multiple profound effects on the developing heart.
388
ASK1 activates the interlinked JNK1/2-ER stress proapoptotic pathway leading to excess 389 apoptosis (Fig. 7B) , and concomitantly suppresses cell cycle progression by repressing cyclin D 390 expression and inducing cell cycle inhibitors (Fig. 7B) VSD heart (right column) from WT embryos of diabetic (DM) dams. In the right, E17.5 heart 615 and blood vessels were imaged in whole mount after an injection of India Ink: a normal heart 616 from WT embryos of nondiabetic dam, a heart with PTA and a heart with right-sided aortic arch Experiments were repeated three times using embryonic hearts from three different dams (n = 3) 639 per group. * significant differences (P < 0.05) compared with other groups. B, XBP1 mRNA 640 splicing in embryonic hearts was detected by reverse transcription and subsequent PCR. n = 2 in 641 this experiment. Because the XBP1 cleavage is clear-cut from not detected to presence, n = 2 is 642 sufficient to support that ASK1 deletion abolishes maternal diabetes-induced XBP1 cleavage. 
